Skip Nav Destination
Issues
Insulin action on muscle protein kinetics and amino acid transport during recovery after resistance exercise.
Diabetes May 1999, Vol.48, 949-957. doi:https://doi.org/10.2337/diabetes.48.5.949
Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans.
B Capaldo; A Gastaldelli; S Antoniello; M Auletta; F Pardo; D Ciociaro; R Guida; E Ferrannini; L Saccà
Diabetes May 1999, Vol.48, 958-966. doi:https://doi.org/10.2337/diabetes.48.5.958
NOD mice have a generalized defect in their response to transplantation tolerance induction.
T G Markees; D V Serreze; N E Phillips; C H Sorli; E J Gordon; L D Shultz; R J Noelle; B A Woda; D L Greiner; J P Mordes; A A Rossini
Diabetes May 1999, Vol.48, 967-974. doi:https://doi.org/10.2337/diabetes.48.5.967
Islet cell membrane antigens activate diabetogenic CD4+ T-cells in the BB/Wor rat.
Diabetes May 1999, Vol.48, 975-982. doi:https://doi.org/10.2337/diabetes.48.5.975
Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients.
Diabetes May 1999, Vol.48, 983-988. doi:https://doi.org/10.2337/diabetes.48.5.983
Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse.
Diabetes May 1999, Vol.48, 989-996. doi:https://doi.org/10.2337/diabetes.48.5.989
Beta-cell hypertrophy in fa/fa rats is associated with basal glucose hypersensitivity and reduced SNARE protein expression.
Diabetes May 1999, Vol.48, 997-1005. doi:https://doi.org/10.2337/diabetes.48.5.997
Sustained proliferation of PDX-1+ cells derived from human islets.
G M Beattie; P Itkin-Ansari; V Cirulli; G Leibowitz; A D Lopez; S Bossie; M I Mally; F Levine; A Hayek
Diabetes May 1999, Vol.48, 1013-1019. doi:https://doi.org/10.2337/diabetes.48.5.1013
Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
H Sandhu; S R Wiesenthal; P E MacDonald; R H McCall; V Tchipashvili; S Rashid; M Satkunarajah; D M Irwin; Z Q Shi; P L Brubaker; M B Wheeler; M Vranic; S Efendic; A Giacca
Diabetes May 1999, Vol.48, 1045-1053. doi:https://doi.org/10.2337/diabetes.48.5.1045
Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach.
S Nagasaka; K Tokuyama; I Kusaka; H Hayashi; K Rokkaku; T Nakamura; A Kawakami; M Higashiyama; S Ishikawa; T Saito
Diabetes May 1999, Vol.48, 1054-1060. doi:https://doi.org/10.2337/diabetes.48.5.1054
Plasma and interstitial glucose dynamics after intravenous glucose injection: evaluation of the single-compartment glucose distribution assumption in the minimal models.
W Regittnig; Z Trajanoski; H J Leis; M Ellmerer; A Wutte; G Sendlhofer; L Schaupp; G A Brunner; P Wach; T R Pieber
Diabetes May 1999, Vol.48, 1070-1081. doi:https://doi.org/10.2337/diabetes.48.5.1070
Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis.
Diabetes May 1999, Vol.48, 1082-1087. doi:https://doi.org/10.2337/diabetes.48.5.1082
Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia.
Diabetes May 1999, Vol.48, 1088-1092. doi:https://doi.org/10.2337/diabetes.48.5.1088
Metabolic and hemodynamic effects of moxonidine in the Zucker diabetic fatty rat model of type 2 diabetes.
Diabetes May 1999, Vol.48, 1093-1100. doi:https://doi.org/10.2337/diabetes.48.5.1093
Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy.
J M Fernández-Real; A Molina; M Broch; W Ricart; C Gutiérrez; R Casamitjana; J Vendrell; J Soler; J M Gómez-Sáez
Diabetes May 1999, Vol.48, 1108-1112. doi:https://doi.org/10.2337/diabetes.48.5.1108
Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.
S Jacob; J Machann; K Rett; K Brechtel; A Volk; W Renn; E Maerker; S Matthaei; F Schick; C D Claussen; H U Häring
Diabetes May 1999, Vol.48, 1113-1119. doi:https://doi.org/10.2337/diabetes.48.5.1113
Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells.
Diabetes May 1999, Vol.48, 1120-1130. doi:https://doi.org/10.2337/diabetes.48.5.1120
Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations.
H Sakamaki; S Akazawa; M Ishibashi; K Izumino; H Takino; H Yamasaki; Y Yamaguchi; S Goto; Y Urata; T Kondo; S Nagataki
Diabetes May 1999, Vol.48, 1138-1144. doi:https://doi.org/10.2337/diabetes.48.5.1138
Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men.
Diabetes May 1999, Vol.48, 1156-1161. doi:https://doi.org/10.2337/diabetes.48.5.1156
Functional study of the E276Q mutant hepatocyte nuclear factor-4alpha found in type 1 maturity-onset diabetes of the young: impaired synergy with chicken ovalbumin upstream promoter transcription factor II on the hepatocyte nuclear factor-1 promoter.
Diabetes May 1999, Vol.48, 1162-1167. doi:https://doi.org/10.2337/diabetes.48.5.1162
Genetic analysis of late-onset type 2 diabetes in a mouse model of human complex trait.
Diabetes May 1999, Vol.48, 1168-1174. doi:https://doi.org/10.2337/diabetes.48.5.1168
A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians.
Diabetes May 1999, Vol.48, 1175-1182. doi:https://doi.org/10.2337/diabetes.48.5.1175
Genetic analysis of obese diabetes in the TSOD mouse.
Diabetes May 1999, Vol.48, 1183-1191. doi:https://doi.org/10.2337/diabetes.48.5.1183
Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes.
J W Kennedy; M F Hirshman; E V Gervino; J V Ocel; R A Forse; S J Hoenig; D Aronson; L J Goodyear; E S Horton
Diabetes May 1999, Vol.48, 1192-1197. doi:https://doi.org/10.2337/diabetes.48.5.1192